Gapicomine

Revision as of 17:47, 4 September 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Gapicomine
Clinical data
Routes of
administration
oral (tablet)
Legal status
Legal status
  • off market (was used in EU countries)
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC12H13N3
Molar mass199.25 g/mol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Gapicomine (INN) is a coronary vasodilator. It has been withdrawn from the market in the countries it was used in.[1]

Also, gapicomine is a major component in the drug bicordin.[2]

History

Gapicomine was discovered in 1970 by Polish chemist Stanisław Biniecki. It was first published about in an article of The Polish Journal of Medicine and Pharmacy describing the derivative drug bicordin in 1974.[3]

References

  1. "Gapicomine Monograph, The Index Nominum". Retrieved 2008-03-31.
  2. "Bicordin, PubChem". Retrieved 2008-03-31.
  3. Samochowiec L, Wójcicki J, Gregorczyk K, Szmatloch E. (1974). "Bicordin--a new drug in the treatment of coronary heart disease". Mater Med Pol.: 298–300. PMID 4453155.

Template:WH Template:WS